Standout Papers

Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of H... 1999 2026 2008 2017 2.5k
  1. Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol (1999)
    Hanna E. Bloomfield, Sander J. Robins et al. New England Journal of Medicine

Immediate Impact

10 from Science/Nature 90 standout
Sub-graph 1 of 15

Citing Papers

The changing landscape of atherosclerosis
2021 StandoutNature
Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease
2019 Standout
55 intermediate papers

Works of Fred H. Faas being referenced

Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
Distribution of lipids in 8,500 men with coronary artery disease
1995
and 3 more

Author Peers

Author Last Decade Papers Cites
Fred H. Faas 2079 787 1992 833 47 3.9k
LeAnne T. Bloedon 1598 748 2406 827 50 4.2k
Hanna Mäenpää 1703 927 2012 731 51 4.7k
Michael C dʼEmden 2831 988 2334 1026 71 5.2k
Benjamin J. Ansell 1600 603 1889 697 32 3.8k
W.J. Howard 1739 475 1484 1089 67 3.8k
Rafael Carmena 2046 673 2037 888 149 4.5k
Jari Stengård 1340 1199 1587 779 52 4.9k
Helmut G. Schrott 2470 521 2652 1310 58 5.2k
Paul Drury 2676 720 1678 1658 87 5.3k
Valentine Charlton-Menys 2132 690 2241 912 37 4.4k

All Works

Loading papers...

Rankless by CCL
2026